Cardiovascular Clinical Studies

This channel includes news and new technology innovations from cardiovascular clinical trials. These clinical studies include all cardiac subspecialties.

Results now available for the first 10 patients being treated with the ELANA open heart bypass solution as part of a SAFE-CAB trial.

News | Cardiovascular Clinical Studies

ELANA Heart Bypass Solution Shows Promising Preliminary Results in First-in-Human Trials

October 11, 2022 — The preliminary results of the first-in-human (FIH) trials for the innovative ELANA Heart Bypass ...

October 11, 2022

Researchers from the University of Minnesota Medical School found that patients with certain features on magnetic resonance imaging (MRI) of the heart are at much higher risk for cardiac sarcoidosis-related adverse outcomes.

News | Cardiac Imaging

Identifying Patients with Sarcoidosis at Risk for Bad Cardiac Outcomes

October 11, 2022 — Researchers from the University of Minnesota Medical School found that patients with certain features ...

October 11, 2022

Grant Proceeds Will Support Pre-Clinical Studies

News | Stents Bioresorbable

Efemoral Medical Awarded Phase II SBIR Grant from NIH to Advance Treatment for Peripheral Artery Disease

October 11, 2022 — Efemoral Medical, developer of advanced interventional bioresorbable therapies, announced that it ...

October 11, 2022

News | Stroke

Identifying How Inflammation Affects Stroke Recovery

October 7, 2022 — A new research grant will enable University of Cincinnati researchers to learn more about how ...

October 07, 2022

This is the first study to investigate the safety and tolerability of NR in a randomized, placebo-controlled trial of patients with heart failure, marking a milestone for future clinical research

News | Heart Failure

ChromaDex Shares Promising Findings from Clinical Study Showcasing the Safety and Tolerability of Nicotinamide Riboside (NR) in Heart Failure With Reduced Ejection Fraction

October 7, 2022 — ChromaDex Corp. announced promising findings from a clinical study, as reported in the peer-reviewed ...

October 07, 2022

Results presented at the Heart Failure Society of America Annual Scientific Meeting

News | Heart Failure

Cleveland Clinic-Led Trial Finds That Increasing Salt Intake Does Not Affect Patients Hospitalized with Congestive Heart Failure During Treatment

October 6, 2022 — Findings from a Cleveland Clinic-led trial show that increasing the salt intake by mouth for patients ...

October 06, 2022

Rutgers study finds post-surgical hospitalization rates from left ventricular assist devices varied by socioeconomic factors

News | Heart Failure

Lower-Income Patients with Heart Pumps More Likely Hospitalized with Major Bleeding, Infection or Heart Failure

October 6, 2022 — The complications experienced by heart failure patients implanted with a left ventricular assist ...

October 06, 2022

CinCor Pharma, Inc. (NASDAQ: CINC) today announced that the company will present Phase 2 data from its BrigHtn trial evaluating baxdrostat in patients with treatment-resistant hypertension as part of the late-breaking science session

News | Hypertension

CinCor Pharma Announces Late-Breaking Presentation of Phase 2 BrigHtn Data for Baxdrostat in Treatment-Resistant Hypertension at the Upcoming 2022 American Heart Association Scientific Sessions

October 5, 2022 — CinCor Pharma, Inc. (NASDAQ: CINC) today announced that the company will present Phase 2 data from ...

October 05, 2022

New analysis adds to growing body of evidence in support of the use of sotagliflozin, an investigational dual SGLT1 and SGLT2 inhibitor, in the treatment of heart failure

News | Heart Failure

New Data Shows Heart Failure Treatment Guided by Daxor’s BVA-100 Lowers Hospital Length of Stay by 55%

October 4, 2022 — Newswise — Daxor Corporation, a global leader in blood volume measurement technology, today announces ...

October 04, 2022

News | Cardiovascular Clinical Studies

New Analysis of Soloist-WHF Trial Underscores Sotagliflozin’s Effect on Reducing Recurrent Heart Failure Events

October 4, 2022 — Lexicon Pharmaceuticals, Inc. announced that a new analysis of results from the SOLOIST-WHF Phase 3out ...

October 04, 2022

12 month data from The PRECISE Trial, the first global, prospective, randomized trial comparing diagnosis and evaluation pathways for stable chest pain, will be presented at the AHA 2022 Scientific Sessions.

News | AHA

HeartFlow Announces Late Breakers Presentation at the 2022 American Heart Association (AHA) Scientific Sessions

October 4, 2022 — HeartFlow, Inc., the leader in revolutionizing precision heart care, announced that the results of the ...

October 04, 2022

The stage is set for the American Heart Association (AHA) Scientific Sessions 2022, to be held November 5-7 at McCormick Place in Chicago, and virtually.

News | AHA

AHA Scientific Sessions 2022 Program, Late-breakers Announced

October 4, 2022 — The American Heart Association (AHA) Scientific Sessions 2022 is set for November 5-7 at McCormick ...

October 04, 2022

Presentations highlight the significant potential clinical benefits of managing congestion in patients with heart failure with FUROSCIX (furosemide injection) at home

News | Heart Failure

scPharmaceuticals Announces Data Presentations at the Heart Failure Society of America 2022 Annual Scientific Meeting

October 3, 2022 — scPharmaceuticals Inc., a pharmaceutical company focused on developing and commercializing products ...

October 03, 2022

Researchers at Mayo Clinic used artificial intelligence (AI) to evaluate patients’ electrocardiograms (ECGs) in a targeted strategy to screen for atrial fibrillation, a common heart rhythm disorder

News | Artificial Intelligence

AI-guided Screening Uses ECG Data to Detect a Hidden Risk Factor for Stroke

September 29, 2022 — Researchers at Mayo Clinic used artificial intelligence (AI) to evaluate patients’ electrocardiogra ...

September 29, 2022

Higher blood levels of collagen-derived molecule predict worse outcomes

News | Heart Failure

Penn Study Identifies New Prognostic Biomarker for Heart Failure

September 29, 2022 — Bloodstream levels of a protein fragment called endotrophin can be used to predict outcomes in ...

September 29, 2022